Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine.

Lamotrigine is associated with immune-related adverse reactions including HLH. HLH is a potentially fatal event; prompt recognition and early therapeutic intervention to mitigate the event is important in improving patient outcomes.